<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1925</article-id><article-id pub-id-type="doi">10.36691/RJA1925</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy</article-title><trans-title-group xml:lang="ru"><trans-title>Хроническая индуцированная крапивница: классификация, современные аспекты диагностики и терапии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8472-1152</contrib-id><contrib-id contrib-id-type="spin">6644-6715</contrib-id><name-alternatives><name xml:lang="en"><surname>Serdotetskova</surname><given-names>Sofia A.</given-names></name><name xml:lang="ru"><surname>Сердотецкова</surname><given-names>Софья Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>darklynx813@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8279-2173</contrib-id><contrib-id contrib-id-type="spin">4547-3948</contrib-id><name-alternatives><name xml:lang="en"><surname>Danilychevа</surname><given-names>Inna V.</given-names></name><name xml:lang="ru"><surname>Данилычева</surname><given-names>Инна Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>ivdanilycheva@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5083-6637</contrib-id><contrib-id contrib-id-type="spin">3023-4538</contrib-id><name-alternatives><name xml:lang="en"><surname>Fomina</surname><given-names>Daria S.</given-names></name><name xml:lang="ru"><surname>Фомина</surname><given-names>Дарья Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.), Assistant Professor</p></bio><bio xml:lang="ru"><p>к.м.н., доцент</p></bio><email>daria_fomina@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4022-3570</contrib-id><contrib-id contrib-id-type="spin">2588-5718</contrib-id><name-alternatives><name xml:lang="en"><surname>Maltseva</surname><given-names>Natalya P.</given-names></name><name xml:lang="ru"><surname>Мальцева</surname><given-names>Наталья Петровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>filippova-nataly@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1212-3767</contrib-id><contrib-id contrib-id-type="spin">3078-0976</contrib-id><name-alternatives><name xml:lang="en"><surname>Kovalkova</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Ковалькова</surname><given-names>Елена Вячеславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ev-kovalkova@ya.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9545-4720</contrib-id><contrib-id contrib-id-type="spin">1857-8154</contrib-id><name-alternatives><name xml:lang="en"><surname>Lebedkina</surname><given-names>Marina S.</given-names></name><name xml:lang="ru"><surname>Лебедкина</surname><given-names>Марина Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>marina.ivanova0808@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1930-5424</contrib-id><contrib-id contrib-id-type="spin">4122-5565</contrib-id><name-alternatives><name xml:lang="en"><surname>Karaulov</surname><given-names>Alexander V.</given-names></name><name xml:lang="ru"><surname>Караулов</surname><given-names>Александр Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>drkaraulov@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2209-7531</contrib-id><contrib-id contrib-id-type="spin">3363-6170</contrib-id><name-alternatives><name xml:lang="en"><surname>Namazova-Baranova</surname><given-names>Leyla S.</given-names></name><name xml:lang="ru"><surname>Намазова-Баранова</surname><given-names>Лейла Сеймуровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>Leyla.s.namazova@gmail.com</email><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7398-0562</contrib-id><contrib-id contrib-id-type="spin">1109-2810</contrib-id><name-alternatives><name xml:lang="en"><surname>Vishneva</surname><given-names>Elena A.</given-names></name><name xml:lang="ru"><surname>Вишнева</surname><given-names>Елена Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>vishneva.e@yandex.ru</email><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2460-7718</contrib-id><contrib-id contrib-id-type="spin">4626-2800</contrib-id><name-alternatives><name xml:lang="en"><surname>Levina</surname><given-names>Julia G.</given-names></name><name xml:lang="ru"><surname>Левина</surname><given-names>Юлия Григорьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>julia.levina@mail.ru</email><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3781-8661</contrib-id><contrib-id contrib-id-type="spin">7168-3817</contrib-id><name-alternatives><name xml:lang="en"><surname>Kalugina</surname><given-names>Vera G.</given-names></name><name xml:lang="ru"><surname>Калугина</surname><given-names>Вера Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>v-starikova@mail.ru</email><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">City Clinical Hospital No. 52</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 52</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Institute of Health Organization and Medical Management of the Department of Health of the City of Moscow</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента Здравоохранения города Москвы</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia</institution></aff><aff><institution xml:lang="ru">Государственный научный центр «Институт иммунологии»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">The Russian National Research Medical University named after N.I. Pirogov</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Petrovsky National Research Centre of Surgery, Research Institute of Pediatrics and Child Health Protection of the Scientific and Clinical Center No. 2</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт педиатрии и охраны здоровья детей Научно-клинического центра №2 Российского научного центра хирургии имени академика Б.В. Петровского</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-02-22" publication-format="electronic"><day>22</day><month>02</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-04-06" publication-format="electronic"><day>06</day><month>04</month><year>2023</year></pub-date><volume>20</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>74</fpage><lpage>96</lpage><history><date date-type="received" iso-8601-date="2023-01-20"><day>20</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-02-06"><day>06</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Фармарус Принт Медиа</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-04-06"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1925">https://rusalljournal.ru/raj/article/view/1925</self-uri><abstract xml:lang="en"><p>Chronic-induced urticaria is a group of diseases characterized by the occurrence of itchy wheals and/or angioedema in response to specific triggers, such as mechanical irritation, exposure to high and low temperatures, vibration, and ultraviolet radiation of various spectra, appearing for ≥6 weeks. This group of diseases is characterized by a long duration, a significant effect on the patient’s quality of life, and the risk of severe life-threatening reactions.</p> <p>The diagnosis of induced urticaria and patient-safe reproduction of symptoms by exposure to a trigger (temperature, mechanical, etc.). Currently, no medical devices have been registered in the Russian Federation for the threshold diagnosis of most physical forms of urticaria. Consequently, diagnosing and dynamic monitoring the state of these patients and their response to treatment are challenging. The question of therapy for chronic-induced urticaria also remains open due to the insufficient effectiveness of the recommended and available treatment methods. This article provides a review of current literature data.</p> <p>This article provides a review of current literature data.</p></abstract><trans-abstract xml:lang="ru"><p>Хроническая индуцированная крапивница ― группа заболеваний, характеризуемая возникновением зудящих волдырей и/или ангиоотёков в ответ на специфические триггеры, такие как механическое раздражение, воздействие высоких и низких температур, вибрация, а также ультрафиолетовое излучение различного спектра, в течение 6 недель и более. Данная группа заболеваний характеризуется длительным течением, существенным снижением качества жизни пациентов, а также риском развития тяжёлых жизнеугрожающих реакций.</p> <p>Диагностика индуцированной крапивницы ― безопасное для пациента воспроизведение симптомов путём воздействия триггера (температурного, механического и т.д.). В настоящий момент в Российской Федерации нет зарегистрированных медицинских приборов для пороговой диагностики большинства физических форм крапивниц, что затрудняет постановку диагноза и динамическое наблюдение за состоянием данных групп пациентов и эффективностью лечения. Открытым остаётся также вопрос о терапии хронической индуцированной крапивницы ввиду недостаточной эффективности рекомендуемых и доступных методов терапии.</p> <p>В статье представлен обзор актуальных литературных данных.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic-induced urticaria</kwd><kwd>provocation testing</kwd><kwd>antihistamines</kwd><kwd>omalizumab</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая индуцированная крапивница</kwd><kwd>провокационное тестирование</kwd><kwd>антигистаминные препараты</kwd><kwd>омализумаб</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Maurer M, Fluhr JW, Khan DA. How to approach chronic inducible urticaria. J Allergy Clin Immunol Pract. 2018;6(4):1119–1130. doi: 10.1016/j.jaip.2018.03.007</mixed-citation><mixed-citation xml:lang="ru">Maurer M., Fluhr J.W., Khan D.A. How to approach chronic inducible urticaria // J Allergy Clin Immunol Pract. 2018. Vol. 6, N 4. Р. 1119–1130. doi: 10.1016/j.jaip.2018.03.007</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Abajian M, Schoepke N, Altrichter S, et al. Physical urticarias and cholinergic urticaria. Immunol Allergy Clin North Am. 2014;34(1): 73–88. doi: 10.1016/j.iac.2013.09.010</mixed-citation><mixed-citation xml:lang="ru">Abajian M., Schoepke N., Altrichter S., et al. Physical urticarias and cholinergic urticaria // Immunol Allergy Clin North Am. 2014. Vol. 34, N 1. Р. 73–88. doi: 10.1016/j.iac.2013.09.010</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Curto-Barredo L, Archilla LR, Vives GR, et al. Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment. Acta Derm Venereol. 2018;98(7):641–647. doi: 10.2340/00015555-2941</mixed-citation><mixed-citation xml:lang="ru">Curto-Barredo L., Archilla L.R., Vives G.R., et al. Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment // Acta Derm Venereol. 2018. Vol. 98, N 7. Р. 641–647. doi: 10.2340/00015555-2941</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Maurer M, Giménez-Arnau A, Ensina LF, et al. Chronic urticaria treatment patterns and changes in quality of life: AWARE Study 2-year results. World Allergy Organ J. 2020;13(9):100460. doi: 10.1016/j.waojou.2020.100460</mixed-citation><mixed-citation xml:lang="ru">Maurer M., Giménez-Arnau A., Ensina L.F., et al. Chronic urticaria treatment patterns and changes in quality of life: AWARE Study 2-year results // World Allergy Organ J. 2020. Vol. 13, N 9. Р. 100460. doi: 10.1016/j.waojou.2020.100460</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Maurer M, Hawro T, Krause K, et al. Diagnosis and treatment of chronic inducible urticaria. Allergy. 2019;74(12):2550–2553. doi: 10.1111/all.13878</mixed-citation><mixed-citation xml:lang="ru">Maurer M., Hawro T., Krause K., et al. Diagnosis and treatment of chronic inducible urticaria // Allergy. 2019. Vol. 74, N 12. Р. 2550–2553. doi: 10.1111/all.13878</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Schoepke N, Młynek A, Weller K, et al. Symptomatic dermographism: An inadequately described disease. J Eur Acad Dermatol Venereol. 2015;29(4):708–712. doi: 10.1111/jdv.12661</mixed-citation><mixed-citation xml:lang="ru">Schoepke N., Młynek A., Weller K., et al. Symptomatic dermographism: An inadequately described disease // J Eur Acad Dermatol Venereol. 2015. Vol. 29, N 4. Р. 708–712. doi: 10.1111/jdv.12661</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Sánchez J, Amaya E, Acevedo A, et al. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: Associated risk factors. J Eur Acad Dermatol Venereol. 2017;5(2):464–470. doi: 10.1016/j.jaip.2016.09.029</mixed-citation><mixed-citation xml:lang="ru">Sánchez J., Amaya E., Acevedo A., et al. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: Associated risk factors // J Eur Acad Dermatol Venereol. 2017. Vol. 5, N 2. Р. 464–470. doi: 10.1016/j.jaip.2016.09.029</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Abajian M, Młynek A, Maurer M. Physical urticaria. Curr Allergy Asthma Rep. 2012;12(4):281–287. doi: 10.1007/s11882-012-0269-0</mixed-citation><mixed-citation xml:lang="ru">Abajian M., Młynek A., Maurer M. Physical urticaria // Curr Allergy Asthma Rep. 2012. Vol. 12, N 4. Р. 281–287. doi: 10.1007/s11882-012-0269-0</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Fleischer M, Grabbe J. [Physical urticaria. (In German)]. Hautarzt. 2004;55(4):344–349. doi: 10.1007/s00105-004-0691-x</mixed-citation><mixed-citation xml:lang="ru">Fleischer M., Grabbe J. [Physical urticaria (In German).] // Hautarzt. 2004. Vol. 55, N 4. Р. 344–349. doi: 10.1007/s00105-004-0691-x</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol. 2007;87(3):196–205. doi: 10.2340/00015555-0240</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T., Maurer M. Urticaria: Current opinions about etiology, diagnosis and therapy // Acta Derm Venereol. 2007. Vol. 87, N 3. Р. 196–205. doi: 10.2340/00015555-0240</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Urticaria (KR). Clinical recommendations, revision 2022. Russian Society of Allergologists and Clinical Immunologists, Russian Society of Dermatovenerologists and Cosmetologists, Union of Pediatricians of Russia; 2019. 57 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Крапивница (КР). Клинические рекомендации, пересмотр 2022 г. Российское общество аллергологов и клинических иммунологов, Российское общество дерматовенерологов и косметологов, Союз педиатров России, 2019. 57 с.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Van der Valk PG, Moret G, Kiemeney LA. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol. 2002;146(1):110–113. doi: 10.1046/j.1365-2133.2002.04582.x</mixed-citation><mixed-citation xml:lang="ru">Van der Valk P.G., Moret G., Kiemeney L.A. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre // Br J Dermatol. 2002. Vol. 146, N 1. Р. 110–113. doi: 10.1046/j.1365-2133.2002.04582.x</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Magerl M, Schmolke J, Metz M, et al. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol. 2009;34(5):e137–e140. doi: 10.1111/j.1365-2230.2008.03097.x</mixed-citation><mixed-citation xml:lang="ru">Magerl M., Schmolke J., Metz M., et al. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg // Clin Exp Dermatol. 2009. Vol. 34, N 5. Р. e137–e140. doi: 10.1111/j.1365-2230.2008.03097.x</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Sharpe GR, Shuster S. The effect of cetirizine on symptoms and wealing in dermographic urticaria. Br J Dermatol. 1993;129(5): 580–583. doi: 10.1111/j.1365-2133.1993.tb00488.x</mixed-citation><mixed-citation xml:lang="ru">Sharpe G.R., Shuster S. The effect of cetirizine on symptoms and wealing in dermographic urticaria // Br J Dermatol. 1993. Vol. 129, N 5. Р. 580–583. doi: 10.1111/j.1365-2133.1993.tb00488.x</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–1414. doi: 10.1111/all.13397</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T., Aberer W., Asero R., et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria // Allergy. 2018. Vol. 73, N 7. Р. 1393–1414. doi: 10.1111/all.13397</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Krause K, Ardelean E, Kessler B, et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010;65(11):1494–1495. doi: 10.1111/j.1398-9995.2010.02409.x</mixed-citation><mixed-citation xml:lang="ru">Krause K., Ardelean E., Kessler B., et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy // Allergy. 2010. Vol. 65, N 11. Р. 1494–1495. doi: 10.1111/j.1398-9995.2010.02409.x</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154(2):177–180. doi: 10.1159/000320233</mixed-citation><mixed-citation xml:lang="ru">Metz M., Altrichter S., Ardelean E., et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria // Int Arch Allergy Immunol. 2011. Vol. 154, N 2. Р. 177–180. doi: 10.1159/000320233</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2018;141(2):638–649. doi: 10.1016/j.jaci.2017.06.032</mixed-citation><mixed-citation xml:lang="ru">Maurer M., Metz M., Brehler R., et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence // J Allergy Clin Immunol. 2018. Vol. 141, N 2. Р. 638–649. doi: 10.1016/j.jaci.2017.06.032</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Maurer M, Schütz A, Weller K, et al. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017;140(3):870–873.e5. doi: 10.1016/j.jaci.2017.01.042</mixed-citation><mixed-citation xml:lang="ru">Maurer M., Schüt A., Weller, K., et al. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial // J Allergy Clin Immunol. 2017. Vol. 140, N 3. Р. 870–873.e5. doi: 10.1016/j.jaci.2017.01.042</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Metz M, Ohanyan T, Church MK, Maurer M. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis. J Dermatol Sci. 2014;73(1):57–62. doi: 10.1016/j.jdermsci.2013.08.011</mixed-citation><mixed-citation xml:lang="ru">Metz M., Ohanyan T., Church M.K., Maurer M. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis // J Dermatol Sci. 2014. Vol. 73, N 1. Р. 57–62. doi: 10.1016/j.jdermsci.2013.08.011</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Metz M, Ohanyan T, Church MK, Maurer M. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. JAMA Dermatol. 2014;150(3):288–290. doi: 10.1001/jamadermatol.2013.8705</mixed-citation><mixed-citation xml:lang="ru">Metz M., Ohanyan T., Church M.K., Maurer M. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria // JAMA Dermatol. 2014. Vol. 150, N 3. Р. 288–290. doi: 10.1001/jamadermatol.2013.8705</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias--The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780–802. doi: 10.1111/all.12884</mixed-citation><mixed-citation xml:lang="ru">Magerl M., Altrichter S., Borzova E., et al. The definition, diagnostic testing, and management of chronic inducible urticarias-- The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision // Allergy. 2016. Vol. 71, N 6. Р. 780–802. doi: 10.1111/all.12884</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Grattan CE. The urticaria spectrum: Recognition of clinical patterns can help management. Clin Exp Dermatol. 2004;29(3): 217–221. doi: 10.1111/j.1365-2230.2004.01494.x</mixed-citation><mixed-citation xml:lang="ru">Grattan C.E. The urticaria spectrum: Recognition of clinical patterns can help management // Clin Exp Dermatol. 2004. Vol. 29, N 3. Р. 217–221. doi: 10.1111/j.1365-2230.2004.01494.x</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Neittaanmäki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13(4):636–644. doi: 10.1016/s0190-9622(85)70208-3</mixed-citation><mixed-citation xml:lang="ru">Neittaanmäki H. Cold urticaria. Clinical findings in 220 patients // J Am Acad Dermatol. 1985. Vol. 13, N 4. Р. 636–644. doi: 10.1016/s0190-9622(85)70208-3</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Siebenhaar F, Staubach P, Metz M, et al. Peltier effect-based temperature challenge: An improved method for diagnosing cold urticaria. J Allergy Clin Immunol. 2004;114(5):1224–1225. doi: 10.1016/j.jaci.2004.07.018</mixed-citation><mixed-citation xml:lang="ru">Siebenhaar F., Staubach P., Metz M., et al. Peltier effect-based temperature challenge: An improved method for diagnosing cold urticaria // J Allergy Clin Immunol. 2004. Vol. 114, N 5. Р. 1224–1225. doi: 10.1016/j.jaci.2004.07.018</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Wanderer AA. Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. J Allergy Clin Immunol. 1990; 85(6):965–981. doi: 10.1016/0091-6749(90)90037-5</mixed-citation><mixed-citation xml:lang="ru">Wanderer A.A. Cold urticaria syndromes: Historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management // J Allergy Clin Immunol. 1990. Vol. 85, N 6. Р. 965–981. doi: 10.1016/0091-6749(90)90037-5</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Siebenhaar F, Weller K, Mlynek A, et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol. 2007;32(3):241–245. doi: 10.1111/j.1365-2230.2007.02376.x</mixed-citation><mixed-citation xml:lang="ru">Siebenhaar F., Weller K., Mlynek A., et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment // Clin Exp Dermatol. 2007. Vol. 32, N 3. Р. 241–245. doi: 10.1111/j.1365-2230.2007.02376.x</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Möller A, Henz BM. Cold urticaria. In: Henz BM, Zuberbier T, Grabbe J, Monroe E, editors. Urticaria. Springer; 1998. Р. 69–78.</mixed-citation><mixed-citation xml:lang="ru">Möller A., Henz B.M. Cold urticaria. In: Henz BM, Zuberbier T, Grabbe J, Monroe E, editors. Urticaria. Springer, 1998. Р. 69–78.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: Recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78(3 Pt 1):417–423. doi: 10.1016/0091-6749(86)90027-8</mixed-citation><mixed-citation xml:lang="ru">Wanderer A.A., Grandel K.E., Wasserman S.I., Farr R.S. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: Recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria // J Allergy Clin Immunol. 1986. Vol. 78, N 3, Pt 1. Р. 417–423. doi: 10.1016/0091-6749(86)90027-8</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Doeglas HM, Rijnten WJ, Schröder FP, Schirm J. Cold urticaria and virus infections: A clinical and serological study in 39 patients. Br J Dermatol. 1986;114(3):311–318. doi: 10.1111/j.1365-2133.1986.tb02822.x</mixed-citation><mixed-citation xml:lang="ru">Doeglas H.M., Rijnten W.J., Schröder F.P., Schirm J. Cold urticaria and virus infections: A clinical and serological study in 39 patients // Br J Dermatol. 1986. Vol. 114, N 3. Р. 311–318. doi: 10.1111/j.1365-2133.1986.tb02822.x</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Jain SV, Mullins RJ. Cold urticaria: A 20-year follow-up study. J Eur Acad Dermatol Venereol. 2016;30(12):2066–2071. doi: 10.1111/jdv.13841</mixed-citation><mixed-citation xml:lang="ru">Jain S.V., Mullins R.J. Cold urticaria: A 20-year follow-up study // J Eur Acad Dermatol Venereol. 2016. Vol. 30, N 12. Р. 2066–2071. doi: 10.1111/jdv.13841</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Deza G, Brasileiro A, Bertolín-Colilla M, et al. Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort. J Am Acad Dermatol. 2016;75(5): 918–924.e2. doi: 10.1016/j.jaad.2016.06.017</mixed-citation><mixed-citation xml:lang="ru">Deza G., Brasileiro A., Bertolín-Colilla M., et al. Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort // J Am Acad Dermatol. 2016. Vol. 75, N 5. Р. 918–924.e2. doi: 10.1016/j.jaad.2016.06.017</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Tannert KL, Skov SP, Jensen BL, et al. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction. Dermatology (Basel, Switzerland). 2012;224(2):101–105. doi: 10.1159/000336572</mixed-citation><mixed-citation xml:lang="ru">Tannert K.L., Skov S.P., Jensen B.L., et al. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction // Dermatology (Basel, Switzerland). 2012. Vol. 224, N 2. Р. 101–105. doi: 10.1159/000336572</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Stepaniuk P, Vostretsova K, Kanani A. Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice. Allergy Asthma Clin Immunol. 2018;(14):85. doi: 10.1186/s13223-018-0310-5</mixed-citation><mixed-citation xml:lang="ru">Stepaniuk P., Vostretsova K., Kanani A. Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice // Allergy Asthma Clin Immunol. 2018. N 14. Р. 85. doi: 10.1186/s13223-018-0310-5</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Mathelier-Fusade P, Aïssaoui M, Bakhos D, et al. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134(1):106–107. doi: 10.1001/archderm.134.1.106</mixed-citation><mixed-citation xml:lang="ru">Mathelier-Fusade P., Aïssaoui M., Bakhos D., et al. Clinical predictive factors of severity in cold urticaria // Arch Dermatol. 1998. Vol. 134, N 1. Р. 106–107. doi: 10.1001/archderm.134.1.106</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Młynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162(1):198–200. doi: 10.1111/j.1365-2133.2009.09441.x</mixed-citation><mixed-citation xml:lang="ru">Młynek A., Magerl M., Siebenhaar F., et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria // Br J Dermatol. 2010. Vol. 162, N 1. Р. 198–200. doi: 10.1111/j.1365-2133.2009.09441.x</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123(3):672–679. doi: 10.1016/j.jaci.2008.12.008</mixed-citation><mixed-citation xml:lang="ru">Siebenhaar F., Degener F., Zuberbier T., et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study // J Allergy Clin Immunol. 2009. Vol. 123, N 3. Р. 672–679. doi: 10.1016/j.jaci.2008.12.008</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Claudy A. Cold urticaria. J Investig Dermatol Symp Proc. 2001;6(2):141–142. doi: 10.1046/j.0022-202x.2001.00028.x</mixed-citation><mixed-citation xml:lang="ru">Claudy A. Cold urticaria // J Investig Dermatol Symp Proc. 2001. Vol. 6, N 2. Р. 141–142. doi: 10.1046/j.0022-202x.2001.00028.x</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Magerl M, Pisarevskaja D, Staubach P, et al. Critical temperature threshold measurement for cold urticaria: A randomized controlled trial of H(1)-antihistamine dose escalation. Br J Dermatol. 2012; 166(5):1095–1099. doi: 10.1111/j.1365-2133.2012.10822.x</mixed-citation><mixed-citation xml:lang="ru">Magerl M., Pisarevskaja D., Staubach P., et al. Critical temperature threshold measurement for cold urticaria: A randomized controlled trial of H(1)-antihistamine dose escalation // Br J Dermatol. 2012. Vol. 166, N 5. Р. 1095–1099. doi: 10.1111/j.1365-2133.2012.10822.x</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Alangari AA, Twarog FJ, Shih MC, Schneider LC. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113(4):e313–e317. doi: 10.1542/peds.113.4.e313</mixed-citation><mixed-citation xml:lang="ru">Alangari A.A., Twarog F.J., Shih M.C., Schneider L.C. Clinical features and anaphylaxis in children with cold urticaria // Pediatrics. 2004. Vol. 113, N 4. Р. e313–e317. doi: 10.1542/peds.113.4.e313</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Kulthanan K, Hunnangkul S, Tuchinda P, et al. Treatments of cold urticaria: A systematic review. J Allergy Clin Immunol. 2019;143(4):1311–1331. doi: 10.1016/j.jaci.2019.02.005</mixed-citation><mixed-citation xml:lang="ru">Kulthanan K., Hunnangkul S., Tuchinda P., et al. Treatments of cold urticaria: A systematic review // J Allergy Clin Immunol. 2019. Vol. 143, N 4. Р. 1311–1331. doi: 10.1016/j.jaci.2019.02.005</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Dressler C, Werner RN, Eisert L, et al. Chronic inducible urticaria: A systematic review of treatment options. J Allergy Clin Immunol. 2018;141(5):1726–1734. doi: 10.1016/j.jaci.2018.01.031</mixed-citation><mixed-citation xml:lang="ru">Dressler C., Werner R.N., Eisert L., et al. Chronic inducible urticaria: A systematic review of treatment options // J Allergy Clin Immunol. 2018. Vol. 141, N 5. Р. 1726–1734. doi: 10.1016/j.jaci.2018.01.031</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T. The personalized treatment for urticaria. In: Bieber T, Nestle F, editors. Personalized treatment options in dermatology. Berlin, Heidelberg: Springer; 2015. Р. 111–120.</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T. The personalized treatment for urticaria. In: Bieber T, Nestle F, editors. Personalized treatment options in dermatology. Berlin, Heidelberg: Springer, 2015. Р. 111–120.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Maltseva N, Borzova E, Fomina D, et al.; COLD-CE Steering Committee. Cold urticaria--What we know and what we do not know. Allergy. 2021;76(4):1077–1094. doi: 10.1111/all.14674</mixed-citation><mixed-citation xml:lang="ru">Maltseva N., Borzova E., Fomina D., et al.; COLD-CE steering committee. Cold urticaria--What we know and what we do not know // Allergy. 2021. Vol. 76, N 4. Р. 1077–1094. doi: 10.1111/all.14674</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Metz M, Schütz A, Weller K, et al. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017;140(3):864–867.e5. doi: 10.1016/j.jaci.2017.01.043</mixed-citation><mixed-citation xml:lang="ru">Metz M., Schütz A., Weller K., et al. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial // J Allergy Clin Immunol. 2017. Vol. 140, N 3. Р. 864–867.e5. doi: 10.1016/j.jaci.2017.01.043</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Marsland AM, Beck MH. Cold urticaria responding to systemic ciclosporin. Br J Dermatol. 2003;149(1):214–215. doi: 10.1046/j.1365-2133.2003.05414.x</mixed-citation><mixed-citation xml:lang="ru">Marsland A.M., Beck M.H. Cold urticaria responding to systemic ciclosporin // Br J Dermatol. 2003. Vol. 149, N 1. Р. 214–215. doi: 10.1046/j.1365-2133.2003.05414.x</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Czarnetzki BM. Ketotifen in cholinergic urticaria. J Allergy Clin Immunol. 1990;86(1):138–139. doi: 10.1016/s0091-6749(05)80136-8</mixed-citation><mixed-citation xml:lang="ru">Czarnetzki B.M. Ketotifen in cholinergic urticaria // J Allergy Clin Immunol. 1990. Vol. 86, N 1. Р. 138–139. doi: 10.1016/s0091-6749(05)80136-8</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Illig L. [On the pathogenesis of cholinergic urticaria. I. Clinical observations and histological studies. (In German)]. Arch Klin Exp Dermatol. 1967;229(3):231–247.</mixed-citation><mixed-citation xml:lang="ru">Illig L. [On the pathogenesis of cholinergic urticaria. I. Clinical observations and histological studies (In German).] //Arch Klin Exp Dermatol. 1967. Vol. 229, N 3. Р. 231–247.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Illig L, Heinicke A. [On the pathogenesis of cholinergic urticaria. II. Studies on the relationships of cholinergic urticaria to sweat secretions with the help of various cholinomimetics. (In German)]. Arch Klin Exp Dermatol. 1967;229(3):285–299.</mixed-citation><mixed-citation xml:lang="ru">Illig L., Heinicke A. [On the pathogenesis of cholinergic urticaria. II. Studies on the relationships of cholinergic urticaria to sweat secretions with the help of various cholinomimetics (In German).] // Arch Klin Exp Dermatol. 1967. Vol. 229, N 3. Р. 285–299.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Illig L, Heinicke A. [On the pathogenesis of cholinergic urticaria. III. The influence of sweat secretion inhibition on cholinergic urticaria. (In German)]. Arch Klin Exp Dermatol. 1967;229(3):345–359.</mixed-citation><mixed-citation xml:lang="ru">Illig L., Heinicke A. [On the pathogenesis of cholinergic urticaria. III. The influence of sweat secretion inhibition on cholinergic urticaria (In German).] // Arch Klin Exp Dermatol. 1967. Vol. 229, N 3. Р. 345–359.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Illig L, Heinicke A. [On the pathogenesis of cholinergic urticaria. IV. On the problem of a true antigen-antibody reaction. (In German)]. Arch Klin Exp Dermatol. 1967;229(3):360–371.</mixed-citation><mixed-citation xml:lang="ru">Illig L., Heinicke A. [On the pathogenesis of cholinergic urticaria. IV. On the problem of a true antigen-antibody reaction (In German).] // Arch Klin Exp Dermatol. 1967. Vol. 229, N 3. Р. 360–371.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Illig L, Heinicke A. [Pathogenesis of cholinergic urticaria. V. The pharmacologic reactivity of the Prausnitz-Kustner reaction and the origin of the antigen. (In German)]. Arch Klin Exp Dermatol. 1967;230(1):34–47.</mixed-citation><mixed-citation xml:lang="ru">Illig L., Heinicke A. [Pathogenesis of cholinergic urticaria. V. The pharmacologic reactivity of the Prausnitz-Kustner reaction and the origin of the antigen (In German).] // Arch Klin Exp Dermatol. 1967. Vol. 230, N 1. Р. 34–47.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Altrichter S, Koch K, Church MK, Maurer M. Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol. 2016;30(12):2060–2065. doi: 10.1111/jdv.13765</mixed-citation><mixed-citation xml:lang="ru">Altrichter S., Koch K., Church M.K., Maurer M. Atopic predisposition in cholinergic urticaria patients and its implications // J Eur Acad Dermatol Venereol. 2016. Vol. 30, N 12. Р. 2060–2065. doi: 10.1111/jdv.13765</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Asady A, Ruft J, Ellrich A, et al. Cholinergic urticaria patients of different age groups have distinct features. Clin Exp Allergy. 2017;47(12):1609–1614. doi: 10.1111/cea.13023</mixed-citation><mixed-citation xml:lang="ru">Asady A., Ruft J., Ellrich A., et al. Cholinergic urticaria patients of different age groups have distinct features // Clin Exp Allergy. 2017. Vol. 47, N 12. Р. 1609–1614. doi: 10.1111/cea.13023</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">Horikawa T, Fukunaga A, Nishigori C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep. 2009; 9(4):273–279. doi: 10.1007/s11882-009-0038-x</mixed-citation><mixed-citation xml:lang="ru">Horikawa T., Fukunaga A., Nishigori C. New concepts of hive formation in cholinergic urticaria // Curr Allergy Asthma Rep. 2009. Vol. 9, N 4. Р. 273–279. doi: 10.1007/s11882-009-0038-x</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Bito T, Sawada Y, Tokura Y. Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int. 2012;61(4):539–544. doi: 10.2332/allergolint.12-RAI-0485</mixed-citation><mixed-citation xml:lang="ru">Bito T., Sawada Y., Tokura Y. Pathogenesis of cholinergic urticaria in relation to sweating // Allergol Int. 2012. Vol. 61, N 4. Р. 539–544. doi: 10.2332/allergolint.12-RAI-0485</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Washio K, Fukunaga A, Onodera M, et al. Clinical characteristics in cholinergic urticaria with palpebral angioedema: Report of 15 cases. J Dermatol Sci. 2017;85(2):135–137. doi: 10.1016/j.jdermsci.2016.11.001</mixed-citation><mixed-citation xml:lang="ru">Washio K., Fukunaga A., Onodera M., et al. Clinical characteristics in cholinergic urticaria with palpebral angioedema: Report of 15 cases // J Dermatol Sci. 2017. Vol. 85, N 2. Р. 135–137. doi: 10.1016/j.jdermsci.2016.11.001</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol. 2005;116(2):397–402. doi: 10.1016/j.jaci.2005.05.024</mixed-citation><mixed-citation xml:lang="ru">Fukunaga A., Bito T., Tsuru K., et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes // J Allergy Clin Immunol. 2005. Vol. 116, N 2. Р. 397–402. doi: 10.1016/j.jaci.2005.05.024</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Sawada Y, Nakamura M, Bito T, et al. Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis. J Invest Dermatol. 2014;134(1):276–279. doi: 10.1038/jid.2013.244</mixed-citation><mixed-citation xml:lang="ru">Sawada Y., Nakamura M., Bito T., et al. Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis // J Invest Dermatol. 2014. Vol. 134, N 1. Р. 276–279. doi: 10.1038/jid.2013.244</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">Fukunaga A, Hatakeyama M, Tsujimoto M, et al. Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol. 2015;172(2): 537–538. doi: 10.1111/bjd.13285</mixed-citation><mixed-citation xml:lang="ru">Fukunaga A., Hatakeyama M., Tsujimoto M., et al. Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis // Br J Dermatol. 2015. Vol. 172, N 2. Р. 537–538. doi: 10.1111/bjd.13285</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">Kim JE, Jung KH, Cho HH, et al. The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes. Int J Dermatol. 2015;54(7): 771–777. doi: 10.1111/ijd.12549</mixed-citation><mixed-citation xml:lang="ru">Kim J.E., Jung K.H., Cho H.H., et al. The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: Cholinergic urticaria may have different subtypes // Int J Dermatol. 2015. Vol. 54, N 7. Р. 771–777. doi: 10.1111/ijd.12549</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">Shelley WB, Rawnsley HM. Aquagenic urticaria. Contact sensitivity reaction to water. JAMA. 1964;(189):895–898.</mixed-citation><mixed-citation xml:lang="ru">Shelley W.B., Rawnsley H.M. Aquagenic urticaria. Contact sensitivity reaction to water // JAMA. 1964. N 189. Р. 895–898.</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Shelley WB, Shelley ED. Follicular dermographism. Cutis. 1983;32(3):244–260.</mixed-citation><mixed-citation xml:lang="ru">Shelley W.B., Shelley E.D. Follicular dermographism // Cutis. 1983. Vol. 32, N 3. Р. 244–260.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">Nakamizo S, Egawa G, Miyachi Y, Kabashima K. Cholinergic urticaria: Pathogenesis-based categorization and its treatment options. J Eur Acad Dermatol Venereol. 2012;26(1):114–116. doi: 10.1111/j.1468-3083.2011.04017.x</mixed-citation><mixed-citation xml:lang="ru">Nakamizo S., Egawa G., Miyachi Y., Kabashima K. Cholinergic urticaria: Pathogenesis-based categorization and its treatment options // J Eur Acad Dermatol Venereol. 2012. Vol. 26, N 1. Р. 114–116. doi: 10.1111/j.1468-3083.2011.04017.x</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">Munetsugu T, Fujimoto T, Oshima Y, et al. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. 2017;44(4):394–400. doi: 10.1111/1346-8138.13649</mixed-citation><mixed-citation xml:lang="ru">Munetsugu T., Fujimoto T., Oshima Y., et al. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan // J Dermatol. 2017. Vol. 44, N 4. Р. 394–400. doi: 10.1111/1346-8138.13649</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">Altrichter S, Salow J, Ardelean E, et al. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J Dermatol Sci. 2014;75(2):88–93. doi: 10.1016/j.jdermsci.2014.04.007</mixed-citation><mixed-citation xml:lang="ru">Altrichter S., Salow J., Ardelean E., et al. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria // J Dermatol Sci. 2014. Vol. 75, N 2. Р. 88–93. doi: 10.1016/j.jdermsci.2014.04.007</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T, Aberer W, Burtin B, et al. Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol. 1995;75(2):147–149. doi: 10.2340/0001555575147149</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T., Aberer W., Burtin B., et al. Efficacy of cetirizine in cholinergic urticaria // Acta Derm Venereol. 1995.Vol. 75, N 2. Р. 147–149. doi: 10.2340/0001555575147149</mixed-citation></citation-alternatives></ref><ref id="B68"><label>68.</label><citation-alternatives><mixed-citation xml:lang="en">Zuberbier T, Münzberger C, Haustein U, et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology (Basel, Switzerland). 1996;193(4):324–327. doi: 10.1159/000246281</mixed-citation><mixed-citation xml:lang="ru">Zuberbier T., Münzberger C., Haustein U., et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria // Dermatology (Basel, Switzerland). 1996. Vol. 193, N 4. Р. 324–327. doi: 10.1159/000246281</mixed-citation></citation-alternatives></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">Koch K, Weller K, Werner A, et al. Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria. J Allergy Clin Immunol. 2016;138(5):1483–1485.e9. doi: 10.1016/j.jaci.2016.05.026</mixed-citation><mixed-citation xml:lang="ru">Koch K., Weller K., Werner A., et al. Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria // J Allergy Clin Immunol. 2016. Vol. 138, N 5. Р. 1483–1485.e9. doi: 10.1016/j.jaci.2016.05.026</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><citation-alternatives><mixed-citation xml:lang="en">Ghazanfar MN, Sand C, Thomsen SF. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: Evaluation of 154 patients. Br J Dermatol. 2016;175(2):404–406. doi: 10.1111/bjd.14540</mixed-citation><mixed-citation xml:lang="ru">Ghazanfar M.N., Sand C., Thomsen S.F. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: Evaluation of 154 patients // Br J Dermatol. 2016. Vol. 175, N 2. Р. 404–406. doi: 10.1111/bjd.14540</mixed-citation></citation-alternatives></ref><ref id="B71"><label>71.</label><citation-alternatives><mixed-citation xml:lang="en">Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63(2):247–249. doi: 10.1111/j.1398-9995.2007.01591.x</mixed-citation><mixed-citation xml:lang="ru">Metz M., Bergmann P., Zuberbier T., Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy // Allergy. 2008. Vol. 63, N 2. Р. 247–249. doi: 10.1111/j.1398-9995.2007.01591.x</mixed-citation></citation-alternatives></ref><ref id="B72"><label>72.</label><citation-alternatives><mixed-citation xml:lang="en">Otto HF, Calabria CW. A case of severe refractory chronic urticaria: A novel method for evaluation and treatment. Allergy Asthma Proc. 2009;30(3):333–337. doi: 10.2500/aap.2009.30.3237</mixed-citation><mixed-citation xml:lang="ru">Otto H.F., Calabria C.W. A case of severe refractory chronic urticaria: A novel method for evaluation and treatment // Allergy Asthma Proc. 2009. Vol. 30, N 3. Р. 333–337. doi: 10.2500/aap.2009.30.3237</mixed-citation></citation-alternatives></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">Sabroe RA. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol. 2010;35(4):e127–e129. doi: 10.1111/j.1365-2230.2009.03748.x</mixed-citation><mixed-citation xml:lang="ru">Sabroe R.A. Failure of omalizumab in cholinergic urticaria // Clin Exp Dermatol. 2010. Vol. 35, N 4. Р. e127–e129. doi: 10.1111/j.1365-2230.2009.03748.x</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">Kutlu A, Tanoglu A, Ozturk S. Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints. Chin Med J (Engl). 2015;128(11):1559–1560. doi: 10.4103/0366-6999.157703</mixed-citation><mixed-citation xml:lang="ru">Kutlu A., Tanoglu A., Ozturk S. Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints // Chin Med J (Engl). 2015. Vol. 128, N 11. Р. 1559–1560. doi: 10.4103/0366-6999.157703</mixed-citation></citation-alternatives></ref><ref id="B75"><label>75.</label><citation-alternatives><mixed-citation xml:lang="en">Ujiie H, Shimizu T, Natsuga K, et al. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines. Clin Exp Dermatol. 2006;31(4):588–589. doi: 10.1111/j.1365-2230.2006.02117.x</mixed-citation><mixed-citation xml:lang="ru">Ujiie H., Shimizu T., Natsuga K., et al. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines // Clin Exp Dermatol. 2006. Vol. 31, N 4. Р. 588–589. doi: 10.1111/j.1365-2230.2006.02117.x</mixed-citation></citation-alternatives></ref><ref id="B76"><label>76.</label><citation-alternatives><mixed-citation xml:lang="en">Altrichter S, Wosny K, Maurer M. Successful treatment of cholinergic urticaria with methantheliniumbromide. J Dermatol. 2015;42(4):422–424. doi: 10.1111/1346-8138.12765</mixed-citation><mixed-citation xml:lang="ru">Altrichter S., Wosny K., Maurer M. Successful treatment of cholinergic urticaria with methantheliniumbromide // J Dermatol. 2015. Vol. 42, N 4. Р. 422–424. doi: 10.1111/1346-8138.12765</mixed-citation></citation-alternatives></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">Feinberg JH, Toner CB. Successful treatment of disabling cholinergic urticaria. Military Med. 2008;173(2):217–220. doi: 10.7205/milmed.173.2.217</mixed-citation><mixed-citation xml:lang="ru">Feinberg J.H., Toner C.B. Successful treatment of disabling cholinergic urticaria // Military Med. 2008. Vol. 173, N 2. Р. 217–220. doi: 10.7205/milmed.173.2.217</mixed-citation></citation-alternatives></ref><ref id="B78"><label>78.</label><citation-alternatives><mixed-citation xml:lang="en">Sheraz A, Halpern S. Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis. Br J Dermatol. 2013;168(6):1369–1370. doi: 10.1111/bjd.12200</mixed-citation><mixed-citation xml:lang="ru">Sheraz A., Halpern S. Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis // Br J Dermatol. 2013. Vol. 168, N 6. Р. 1369–1370. doi: 10.1111/bjd.12200</mixed-citation></citation-alternatives></ref><ref id="B79"><label>79.</label><citation-alternatives><mixed-citation xml:lang="en">Berth-Jones J, Graham-Brown RA. Cholinergic pruritus, erythema and urticaria: A disease spectrum responding to danazol. Br J Dermatol. 1989;121(2):235–237. doi: 10.1111/j.1365-2133.1989.tb01804.x</mixed-citation><mixed-citation xml:lang="ru">Berth-Jones J., Graham-Brown R.A. Cholinergic pruritus, erythema and urticaria: A disease spectrum responding to danazol // Br J Dermatol. 1989. Vol. 121, N 2. Р. 235–237. doi: 10.1111/j.1365-2133.1989.tb01804.x</mixed-citation></citation-alternatives></ref><ref id="B80"><label>80.</label><citation-alternatives><mixed-citation xml:lang="en">La Shell MS, England RW. Severe refractory cholinergic urticaria treated with danazol. J Drugs Dermatol. 2006);5(7):664–667.</mixed-citation><mixed-citation xml:lang="ru">La Shell M.S., England R.W. Severe refractory cholinergic urticaria treated with danazol // J Drugs Dermatol. 2006. Vol. 5, N 7. Р. 664–667.</mixed-citation></citation-alternatives></ref><ref id="B81"><label>81.</label><citation-alternatives><mixed-citation xml:lang="en">Wong E, Eftekhari N, Greaves MW, Ward AM. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol. 1987;116(4):553–556. doi: 10.1111/j.1365-2133.1987.tb05877.x</mixed-citation><mixed-citation xml:lang="ru">Wong E., Eftekhari N., Greaves M.W., Ward A.M. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria // Br J Dermatol. 1987. Vol. 116, N 4. Р. 553–556. doi: 10.1111/j.1365-2133.1987.tb05877.x</mixed-citation></citation-alternatives></ref><ref id="B82"><label>82.</label><citation-alternatives><mixed-citation xml:lang="en">Lawlor F, Black AK. Delayed pressure urticaria. Immunol Allergy Clin North Am. 2004;24(2):247-vii. doi: 10.1016/j.iac.2004.01.006</mixed-citation><mixed-citation xml:lang="ru">Lawlor F., Black A.K. Delayed pressure urticaria // Immunol Allergy Clin North Am. 2004. Vol. 24, N 2. Р. 247-vii. doi: 10.1016/j.iac.2004.01.006</mixed-citation></citation-alternatives></ref><ref id="B83"><label>83.</label><citation-alternatives><mixed-citation xml:lang="en">Hermes B, Prochazka AK, Haas N, et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol. 1999;103 (2 Pt 1):307–314. doi: 10.1016/s0091-6749(99)70506-3</mixed-citation><mixed-citation xml:lang="ru">Hermes B., Prochazka A.K., Haas N., et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria // J Allergy Clin Immunol. 1999. Vol. 103, N 2, Pt 1. Р. 307–314. doi: 10.1016/s0091-6749(99)70506-3</mixed-citation></citation-alternatives></ref><ref id="B84"><label>84.</label><citation-alternatives><mixed-citation xml:lang="en">Ryan TJ, Shim-Young N, Turk JL. Delayed pressure urticaria. Br J Dermatol. 1968;80(8):485–490. doi: 10.1111/j.1365-2133.1968.tb12334.x</mixed-citation><mixed-citation xml:lang="ru">Ryan T.J., Shim-Young N., Turk J.L. Delayed pressure urticaria // Br J Dermatol. 1968. Vol. 80, N 8. Р. 485–490. doi: 10.1111/j.1365-2133.1968.tb12334.x</mixed-citation></citation-alternatives></ref><ref id="B85"><label>85.</label><citation-alternatives><mixed-citation xml:lang="en">Barlow RJ, Warburton F, Watson K, et al. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol. 1993;29(6):954–958. doi: 10.1016/0190-9622(93)70273-v</mixed-citation><mixed-citation xml:lang="ru">Barlow R.J., Warburton F., Watson K., et al. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria // J Am Acad Dermatol. 1993. Vol. 29, N 6. Р. 954–958. doi: 10.1016/0190-9622(93)70273-v</mixed-citation></citation-alternatives></ref><ref id="B86"><label>86.</label><citation-alternatives><mixed-citation xml:lang="en">Lawlor F, Black AK, Ward AM, et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol. 1989;120(3):403–408. doi: 10.1111/j.1365-2133.1989.tb04167.x</mixed-citation><mixed-citation xml:lang="ru">Lawlor F., Black A.K., Ward A.M., et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine // Br J Dermatol. 1989. Vol. 120, N 3. Р. 403–408. doi: 10.1111/j.1365-2133.1989.tb04167.x</mixed-citation></citation-alternatives></ref><ref id="B87"><label>87.</label><citation-alternatives><mixed-citation xml:lang="en">Magerl M, Philipp S, Manasterski M, et al. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol. 2007;119(3):752–754. doi: 10.1016/j.jaci.2006.12.658</mixed-citation><mixed-citation xml:lang="ru">Magerl M., Philipp S., Manasterski M., et al. Successful treatment of delayed pressure urticaria with anti-TNF-alpha // J Allergy Clin Immunol. 2007. Vol. 119, N 3. Р. 752–754. doi: 10.1016/j.jaci.2006.12.658</mixed-citation></citation-alternatives></ref><ref id="B88"><label>88.</label><citation-alternatives><mixed-citation xml:lang="en">Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: An evidence-based review, Part 1. Ann Allergy Asthma Immunol. 2008;100(5)403–468. doi: 10.1016/S1081-1206(10)60462-0</mixed-citation><mixed-citation xml:lang="ru">Morgan M., Khan D.A. Therapeutic alternatives for chronic urticaria: An evidence-based review, Part 1 // Ann Allergy Asthma Immunol. 2008. Vol. 100, N 5. Р. 403–468. doi: 10.1016/S1081-1206(10)60462-0</mixed-citation></citation-alternatives></ref><ref id="B89"><label>89.</label><citation-alternatives><mixed-citation xml:lang="en">Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: An evidence-based review. Part 2 // Ann Allergy Asthma Immunol. 2008;100(6):517–544. doi: 10.1016/S1081-1206(10)60047-6</mixed-citation><mixed-citation xml:lang="ru">Morgan M., Khan D.A. Therapeutic alternatives for chronic urticaria: An evidence-based review, Part 2 // Ann Allergy Asthma Immunol. 2008. Vol. 100, N 6. Р. 517–544. doi: 10.1016/S1081-1206(10)60047-6</mixed-citation></citation-alternatives></ref><ref id="B90"><label>90.</label><citation-alternatives><mixed-citation xml:lang="en">Eskeland S, Tanum L, Halvorsen JA. Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram. Clin Exp Dermatol. 2016;41(5):526–528. doi: 10.1111/ced.12851</mixed-citation><mixed-citation xml:lang="ru">Eskeland S., Tanum L., Halvorsen J.A. Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram // Clin Exp Dermatol. 2016. Vol. 41, N 5. Р. 526–528. doi: 10.1111/ced.12851</mixed-citation></citation-alternatives></ref><ref id="B91"><label>91.</label><citation-alternatives><mixed-citation xml:lang="en">Swerlick RA, Puar N. Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients. Dermatol Ther. 2015;28(5):318–322. doi: 10.1111/dth.12266</mixed-citation><mixed-citation xml:lang="ru">Swerlick R.A., Puar N. Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients // Dermatol Ther. 2015. Vol. 28, N 5. Р. 318–322. doi: 10.1111/dth.12266</mixed-citation></citation-alternatives></ref><ref id="B92"><label>92.</label><citation-alternatives><mixed-citation xml:lang="en">Samarasinghe V, Marsland AM. Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria. Clin Exp Dermatol. 2012; 37(7):741–743. doi: 10.1111/j.1365-2230.2011.04281.x</mixed-citation><mixed-citation xml:lang="ru">Samarasinghe V., Marsland A.M. Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria // Clin Exp Dermatol. 2012. Vol. 37, N 7. Р. 741–743. doi: 10.1111/j.1365-2230.2011.04281.x</mixed-citation></citation-alternatives></ref><ref id="B93"><label>93.</label><citation-alternatives><mixed-citation xml:lang="en">Grundmann SA, Kiefer S, Luger TA, Brehler R. Delayed pressure urticaria--dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011;9(11):908–912. doi: 10.1111/j.1610-0387.2011.07749.x</mixed-citation><mixed-citation xml:lang="ru">Grundmann S.A., Kiefer S., Luger T.A., Brehler R. Delayed pressure urticaria--dapsone heading for first-line therapy? // J Dtsch Dermatol Ges. 2011. Vol. 9, N 11. Р. 908–912. doi: 10.1111/j.1610-0387.2011.07749.x</mixed-citation></citation-alternatives></ref><ref id="B94"><label>94.</label><citation-alternatives><mixed-citation xml:lang="en">Shedden C, Highet AS. Delayed pressure urticaria controlled by tranexamic acid. Clin Exp Dermatol. 2006;31(2):295–296. doi: 10.1111/j.1365-2230.2005.02014.x</mixed-citation><mixed-citation xml:lang="ru">Shedden C., Highet A.S. Delayed pressure urticaria controlled by tranexamic acid // Clin Exp Dermatol. 2006. Vol. 31, N 2. Р. 295–296. doi: 10.1111/j.1365-2230.2005.02014.x</mixed-citation></citation-alternatives></ref><ref id="B95"><label>95.</label><citation-alternatives><mixed-citation xml:lang="en">Kalogeromitros D, Kempuraj D, Katsarou-Katsari A, et al. Theophylline as “add-on” therapy in patients with delayed pressure urticaria: A prospective self-controlled study. Int J Immunopathol Pharmacol. 2005;18(3):595–602. doi: 10.1177/039463200501800320</mixed-citation><mixed-citation xml:lang="ru">Kalogeromitros D., Kempuraj D., Katsarou-Katsari A., et al. Theophylline as “add-on” therapy in patients with delayed pressure urticaria: A prospective self-controlled study // Int J Immunopathol Pharmacol. 2005. Vol. 18, N 3. Р. 595–602. doi: 10.1177/039463200501800320</mixed-citation></citation-alternatives></ref><ref id="B96"><label>96.</label><citation-alternatives><mixed-citation xml:lang="en">Dawn G, Urcelay M, Ah-Weng A, et al. Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria. Br J Dermatol. 2003;149(4):836–840. doi: 10.1046/j.1365-2133.2003.05486.x</mixed-citation><mixed-citation xml:lang="ru">Dawn G., Urcelay M., Ah-Weng A., et al. Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria // Br J Dermatol. 2003. Vol. 149, N 4. Р. 836–840. doi: 10.1046/j.1365-2133.2003.05486.x</mixed-citation></citation-alternatives></ref><ref id="B97"><label>97.</label><citation-alternatives><mixed-citation xml:lang="en">Nettis E, Pannofino A, Cavallo E, et al. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol. 2003;112(1):212–213. doi: 10.1067/mai.2003.1559</mixed-citation><mixed-citation xml:lang="ru">Nettis E., Pannofino A., Cavallo E., et al. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria // J Allergy Clin Immunol. 2003. Vol. 112, N 1. Р. 212–213. doi: 10.1067/mai.2003.1559</mixed-citation></citation-alternatives></ref><ref id="B98"><label>98.</label><citation-alternatives><mixed-citation xml:lang="en">Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: A case report. Allergy. 2010;65(1):138–139. doi: 10.1111/j.1398-9995.2009.02188.x</mixed-citation><mixed-citation xml:lang="ru">Bindslev-Jensen C., Skov P.S. Efficacy of omalizumab in delayed pressure urticaria: A case report // Allergy. 2010. Vol. 65, N 1. Р. 138–139. doi: 10.1111/j.1398-9995.2009.02188.x</mixed-citation></citation-alternatives></ref><ref id="B99"><label>99.</label><citation-alternatives><mixed-citation xml:lang="en">Quintero OP, Arrondo AP, Veleiro B. Rapid response to omalizumab in 3 cases of delayed pressure urticaria. J Allergy Clin Immunol Pract. 2017;5(1):179–180. doi: 10.1016/j.jaip.2016.07.016</mixed-citation><mixed-citation xml:lang="ru">Quintero O.P., Arrondo A.P., Veleiro B. Rapid response to omalizumab in 3 cases of delayed pressure urticaria // J Allergy Clin Immunol Pract. 2017. Vol. 5, N 1. Р. 179–180. doi: 10.1016/j.jaip.2016.07.016</mixed-citation></citation-alternatives></ref><ref id="B100"><label>100.</label><citation-alternatives><mixed-citation xml:lang="en">Netchiporouk E, Nguyen CH, Thuraisingham T, et al. Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: Case series. Pediatr Allergy Immunol. 2015;26(6):585–588. doi: 10.1111/pai.12407</mixed-citation><mixed-citation xml:lang="ru">Netchiporouk E., Nguyen C.H., Thuraisingham T., et al. Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series // Pediatr Allergy Immunol. 2015. Vol. 26, N 6. Р. 585–588. doi: 10.1111/pai.12407</mixed-citation></citation-alternatives></ref><ref id="B101"><label>101.</label><citation-alternatives><mixed-citation xml:lang="en">Kasperska-Zajac A, Jarząb J, Żerdzińska A, et al. Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature. Int J Immunopathol Pharmacol. 2016;29(2):320–328. doi: 10.1177/0394632015623795</mixed-citation><mixed-citation xml:lang="ru">Kasperska-Zajac A., Jarząb J., Żerdzińska A., et al. Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature // Int J Immunopathol Pharmacol. 2016. Vol. 29, N 2. Р. 320–328. doi: 10.1177/0394632015623795</mixed-citation></citation-alternatives></ref><ref id="B102"><label>102.</label><citation-alternatives><mixed-citation xml:lang="en">Milanesi N, Gola M, Francalanci S. Evaluation of nine patients with solar urticaria during summer. G Ital Dermatol Venereol. 2020; 155(6):800–802. doi: 10.23736/S0392-0488.19.06176-5</mixed-citation><mixed-citation xml:lang="ru">Milanesi N., Gola M., Francalanci S. Evaluation of nine patients with solar urticaria during summer // G Ital Dermatol Venereol. 2020. Vol. 155, N 6. Р. 800–802. doi: 10.23736/S0392-0488.19.06176-5</mixed-citation></citation-alternatives></ref><ref id="B103"><label>103.</label><citation-alternatives><mixed-citation xml:lang="en">Snast I, Lapidoth M, Uvaidov V, et al. Real-life experience in the treatment of solar urticaria: Retrospective cohort study. Clin Exp Dermatol. 2019;44(5):e164–e170. doi: 10.1111/ced.13960</mixed-citation><mixed-citation xml:lang="ru">Snast I., Lapidoth M., Uvaidov V., et al. Real-life experience in the treatment of solar urticaria: Retrospective cohort study // Clin Exp Dermatol. 2019. Vol. 44, N 5. Р. e164–e170. doi: 10.1111/ced.13960</mixed-citation></citation-alternatives></ref><ref id="B104"><label>104.</label><citation-alternatives><mixed-citation xml:lang="en">Photiou L, Foley P, Ross G. Solar urticaria--An Australian case series of 83 patients. Australas J Dermatol. 2019;60(2):110–117. doi: 10.1111/ajd.12975</mixed-citation><mixed-citation xml:lang="ru">Photiou L., Foley P., Ross G. Solar urticaria--An Australian case series of 83 patients // Australas J Dermatol. 2019. Vol. 60, N 2. Р. 110–117. doi: 10.1111/ajd.12975</mixed-citation></citation-alternatives></ref><ref id="B105"><label>105.</label><citation-alternatives><mixed-citation xml:lang="en">Lyons AB, Peacock A, Zubair R, et al. Successful treatment of solar urticaria with UVA1 hardening in three patients. Photodermatol Photoimmunol Photomed. 2019;35(3):193–195. doi: 10.1111/phpp.12447</mixed-citation><mixed-citation xml:lang="ru">Lyons A.B., Peacock A., Zubair R., et al. Successful treatment of solar urticaria with UVA1 hardening in three patients // Photodermatol Photoimmunol Photomed. 2019. Vol. 35, N 3. Р. 193–195. doi: 10.1111/phpp.12447</mixed-citation></citation-alternatives></ref><ref id="B106"><label>106.</label><citation-alternatives><mixed-citation xml:lang="en">Snyder M, Turrentine JE, Cruz PD. Photocontact dermatitis and its clinical mimics: an overview for the allergist. Clin Rev Allergy Immunol. 2019;56(1):32–40. doi: 10.1007/s12016-018-8696-x</mixed-citation><mixed-citation xml:lang="ru">Snyder M., Turrentine J.E., Cruz P.D. Photocontact dermatitis and its clinical mimics: An overview for the allergist // Clin Rev Allergy Immunol. 2019. Vol. 56, N 1. Р. 32–40. doi: 10.1007/s12016-018-8696-x</mixed-citation></citation-alternatives></ref><ref id="B107"><label>107.</label><citation-alternatives><mixed-citation xml:lang="en">Fityan A, McGibbon D, Fassihi H, Sarkany RS. Paediatric solar urticaria: A case series. Br J Dermatol. 2018;178(6):1453–1454. doi: 10.1111/bjd.16325</mixed-citation><mixed-citation xml:lang="ru">Fityan A., McGibbon D., Fassihi H., Sarkany R.S. Paediatric solar urticaria: A case series // Br J Dermatol. 2018. Vol. 178, N 6. Р. 1453–1454. doi: 10.1111/bjd.16325</mixed-citation></citation-alternatives></ref><ref id="B108"><label>108.</label><citation-alternatives><mixed-citation xml:lang="en">Raigosa M, Toro Y, Sánchez J. [Solar urticaria. Case report and literature review. (In Spanish)]. Rev Alerg Mex. 2017;64(3):371–375. doi: 10.29262/ram.v64i3.202</mixed-citation><mixed-citation xml:lang="ru">Raigosa M., Toro Y., Sánchez J. [Solar urticaria. Case report and literature review (In Spanish).] // Rev Alerg Mex. 2017. Vol. 64, N 3. Р. 371–375. doi: 10.29262/ram.v64i3.202</mixed-citation></citation-alternatives></ref><ref id="B109"><label>109.</label><citation-alternatives><mixed-citation xml:lang="en">Goetze S, Elsner P. Solar urticaria. J Dtsch Dermatol Ges. 2015;13(12):1250–1253. doi: 10.1111/ddg.12809</mixed-citation><mixed-citation xml:lang="ru">Goetze S., Elsner P. Solar urticaria // J Dtsch Dermatol Ges. 2015. Vol. 13, N 12. Р. 1250–1253. doi: 10.1111/ddg.12809</mixed-citation></citation-alternatives></ref><ref id="B110"><label>110.</label><citation-alternatives><mixed-citation xml:lang="en">Snast I, Kremer N, Lapidoth M, et al. Omalizumab for the treatment of solar urticaria: Case series and systematic review of the literature. J Allergy Clin Immunol Pract. 2018;6(4):1198–1204.e3. doi: 10.1016/j.jaip.2018.02.032</mixed-citation><mixed-citation xml:lang="ru">Snast I., Kremer N., Lapidoth M., et al. Omalizumab for the treatment of solar urticaria: Case series and systematic review of the literature // J Allergy Clin Immunol Pract. 2018. Vol. 6, N 4. Р. 1198–1204.e3. doi: 10.1016/j.jaip.2018.02.032</mixed-citation></citation-alternatives></ref><ref id="B111"><label>111.</label><citation-alternatives><mixed-citation xml:lang="en">Morgado-Carrasco D, Fustà-Novell X, Podlipnik S, et al. Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature. Photodermatol Photoimmunol Photomed. 2018;34(3):194–199. doi: 10.1111/phpp.12370</mixed-citation><mixed-citation xml:lang="ru">Morgado-Carrasco D., Fustà-Novell X., Podlipnik S., et al. Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature // Photodermatol Photoimmunol Photomed. 2018. Vol. 34, N 3. Р. 194–199. doi: 10.1111/phpp.12370</mixed-citation></citation-alternatives></ref><ref id="B112"><label>112.</label><citation-alternatives><mixed-citation xml:lang="en">Harris BW, Badri T, Schlessinger J. Solar Urticaria. In: StatPearls. StatPearls Publishing; 2022.</mixed-citation><mixed-citation xml:lang="ru">Harris B.W., Badri T., Schlessinger J. Solar Urticaria. In: StatPearls. StatPearls Publishing, 2022.</mixed-citation></citation-alternatives></ref><ref id="B113"><label>113.</label><citation-alternatives><mixed-citation xml:lang="en">Arasi S, Crisafulli G, Caminiti L, et al. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria. Pediatr Allergy Immunol. 2015;26(6):583–585. doi: 10.1111/pai.12413</mixed-citation><mixed-citation xml:lang="ru">Arasi S., Crisafulli G., Caminiti L., et al. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria // Pediatr Allergy Immunol. 2015. Vol. 26, N 6. Р. 583–585. doi: 10.1111/pai.12413</mixed-citation></citation-alternatives></ref><ref id="B114"><label>114.</label><citation-alternatives><mixed-citation xml:lang="en">Baliu-Piqué C, Aguilera Peiró P. Three cases of solar urticaria successfully treated with omalizumab. J Eur Acad Dermatol Venereol. 2016;30(4):704–706. doi: 10.1111/jdv.13001</mixed-citation><mixed-citation xml:lang="ru">Baliu-Piqué C., Aguilera Peiró P. Three cases of solar urticaria successfully treated with omalizumab // J Eur Acad Dermatol Venereol. 2016. Vol. 30, N 4. Р. 704–706. doi: 10.1111/jdv.13001</mixed-citation></citation-alternatives></ref><ref id="B115"><label>115.</label><citation-alternatives><mixed-citation xml:lang="en">Combalia A, Fernández-Sartorio C, Aguilera P. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest. Actas Dermosifiliogr. 2017;108(6):593–594. doi: 10.1016/j.ad.2016.11.015</mixed-citation><mixed-citation xml:lang="ru">Combalia A., Fernández-Sartorio C., Aguilera P. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest // Actas Dermosifiliogr. 2017. Vol. 108, N 6. Р. 593–594. doi: 10.1016/j.ad.2016.11.015</mixed-citation></citation-alternatives></ref><ref id="B116"><label>116.</label><citation-alternatives><mixed-citation xml:lang="en">De Dios-Velázquez Á, González-de Arriba M, Beteta-Gorriti V, et al. Effectiveness of omalizumab in severe solar urticaria. Ann Allergy Asthma Immunol. 2016;116(3):260–262. doi: 10.1016/j.anai.2015.12.023</mixed-citation><mixed-citation xml:lang="ru">De Dios-Velázquez Á., González-de Arriba M., Beteta-Gorriti V., et al. Effectiveness of omalizumab in severe solar urticaria // Ann Allergy Asthma Immunol. 2016. Vol. 116, N 3. Р. 260–262. doi: 10.1016/j.anai.2015.12.023</mixed-citation></citation-alternatives></ref><ref id="B117"><label>117.</label><citation-alternatives><mixed-citation xml:lang="en">Güzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63(11):1563–1565. doi: 10.1111/j.1398-9995.2008.01879.x</mixed-citation><mixed-citation xml:lang="ru">Güzelbey O., Ardelean E., Magerl M., et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy // Allergy. 2008. Vol. 63, N 11. Р. 1563–1565. doi: 10.1111/j.1398-9995.2008.01879.x</mixed-citation></citation-alternatives></ref><ref id="B118"><label>118.</label><citation-alternatives><mixed-citation xml:lang="en">Moncourier M, Assikar S, Matei I, et al. Visible light-induced solar urticaria is improved by omalizumab. Photodermatol Photoimmunol Photomed. 2016;32(5-6):314–316. doi: 10.1111/phpp.12271</mixed-citation><mixed-citation xml:lang="ru">Moncourier M., Assikar S., Matei I., et al. Visible light-induced solar urticaria is improved by omalizumab // Photodermatol Photoimmunol Photomed. 2016. Vol. 32, N 5-6. Р. 314–316. doi: 10.1111/phpp.12271</mixed-citation></citation-alternatives></ref><ref id="B119"><label>119.</label><citation-alternatives><mixed-citation xml:lang="en">Terrani I, Bircher AJ, Hofmeier SK. Solar urticaria induced by visible light: Successful treatment with omalizumab. Clin Exp Dermatol. 2016;41(8):890–892. doi: 10.1111/ced.12951</mixed-citation><mixed-citation xml:lang="ru">Terrani I., Bircher A.J., Hofmeier S.K. Solar urticaria induced by visible light: Successful treatment with omalizumab // Clin Exp Dermatol. 2016. Vol. 41, N 8. Р. 890–892. doi: 10.1111/ced.12951</mixed-citation></citation-alternatives></ref><ref id="B120"><label>120.</label><citation-alternatives><mixed-citation xml:lang="en">Brüning JH, Ziemer M, Pemler S, et al. Successful treatment of solar urticaria with omalizumab. J Dtsch Dermatol Ges. 2016;14(9):936–937. doi: 10.1111/ddg.13017</mixed-citation><mixed-citation xml:lang="ru">Brüning J.H., Ziemer M., Pemler S., et al. Successful treatment of solar urticaria with omalizumab // J Dtsch Dermatol Ges. 2016. Vol. 14, N 9. Р. 936–937. doi: 10.1111/ddg.13017</mixed-citation></citation-alternatives></ref><ref id="B121"><label>121.</label><citation-alternatives><mixed-citation xml:lang="en">Levi A, Tal Y, Dranitzki Z, et al. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child. Pediatr Allergy Immunol. 2015;26(6):588–590. doi: 10.1111/pai.12441</mixed-citation><mixed-citation xml:lang="ru">Levi A., Tal Y., Dranitzki Z., et al. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child // Pediatr Allergy Immunol. 2015. Vol. 26, N 6. Р. 588–590. doi: 10.1111/pai.12441</mixed-citation></citation-alternatives></ref><ref id="B122"><label>122.</label><citation-alternatives><mixed-citation xml:lang="en">Müller S, Schempp CM, Jakob T. Failure of omalizumab in the treatment of solar urticaria. J Eur Acad Dermatol Venereol. 2016;30(3):524–525. doi: 10.1111/jdv.12922</mixed-citation><mixed-citation xml:lang="ru">Müller S., Schempp C.M., Jakob T. Failure of omalizumab in the treatment of solar urticaria // J Eur Acad Dermatol Venereol. 2016. Vol. 30, N 3. Р. 524–525. doi: 10.1111/jdv.12922</mixed-citation></citation-alternatives></ref><ref id="B123"><label>123.</label><citation-alternatives><mixed-citation xml:lang="en">Darling M, Lambiase MC, Hodson DS. Localized heat induced urticaria: Report of a case. J Drugs Dermatol. 2004;3(1):75–76.</mixed-citation><mixed-citation xml:lang="ru">Darling M., Lambiase M.C., Hodson D.S. Localized heat induced urticaria: Report of a case // J Drugs Dermatol. 2004. Vol. 3, N 1. Р. 75–76.</mixed-citation></citation-alternatives></ref><ref id="B124"><label>124.</label><citation-alternatives><mixed-citation xml:lang="en">Pezzolo E, Peroni A, Gisond P., Girolomoni G. Heat urticaria: A revision of published cases with an update on classification and management. Br J Dermatol. 2016;175(3):473–478. doi: 10.1111/bjd.14543</mixed-citation><mixed-citation xml:lang="ru">Pezzolo E., Peroni A., Gisondi P., Girolomoni G. Heat urticaria: A revision of published cases with an update on classification and management // Br J Dermatol. 2016. Vol. 175, N 3. Р. 473–478. doi: 10.1111/bjd.14543</mixed-citation></citation-alternatives></ref><ref id="B125"><label>125.</label><citation-alternatives><mixed-citation xml:lang="en">Carballada F, Nuñez R, Martin-Lazaro J, et al. Omalizumab treatment in 2 cases of refractory heat urticaria. J Investig Allergol Clin Immunol. 2013;23(7):519–521.</mixed-citation><mixed-citation xml:lang="ru">Carballada F., Nuñez R., Martin-Lazaro J., et al. Omalizumab treatment in 2 cases of refractory heat urticaria // J Investig Allergol Clin Immunol. 2013. Vol. 23, N 7. Р. 519–521.</mixed-citation></citation-alternatives></ref><ref id="B126"><label>126.</label><citation-alternatives><mixed-citation xml:lang="en">Bullerkotte U, Wieczorek D, Kapp A, Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010;65(7):931–932. doi: 10.1111/j.1398-9995.2009.02268.x</mixed-citation><mixed-citation xml:lang="ru">Bullerkotte U., Wieczorek D., Kapp A., Wedi B. Effective treatment of refractory severe heat urticaria with omalizumab // Allergy. 2010. Vol. 65, N 7. Р. 931–932. doi: 10.1111/j.1398-9995.2009.02268.x</mixed-citation></citation-alternatives></ref><ref id="B127"><label>127.</label><citation-alternatives><mixed-citation xml:lang="en">Boyden SE, Desai A, Cruse G, et al. Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med. 2016;374(7): 656–663. doi: 10.1056/NEJMoa1500611</mixed-citation><mixed-citation xml:lang="ru">Boyden S.E., Desai A., Cruse G., et al. Vibratory urticaria associated with a missense variant in ADGRE2 // N Engl J Med. 2016. Vol. 374, N 7. Р. 656–663. doi: 10.1056/NEJMoa1500611</mixed-citation></citation-alternatives></ref><ref id="B128"><label>128.</label><citation-alternatives><mixed-citation xml:lang="en">Pressler A, Grosber M, Halle M, et al. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angioedema. Clin Exp Dermatol. 2013;38(2):151–153. doi: 10.1111/j.1365-2230.2012.04430.x</mixed-citation><mixed-citation xml:lang="ru">Pressler A., Grosber M., Halle M., et al. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angioedema // Clin Exp Dermatol. 2013. Vol. 38, N 2. Р. 151–153. doi: 10.1111/j.1365-2230.2012.04430.x</mixed-citation></citation-alternatives></ref><ref id="B129"><label>129.</label><citation-alternatives><mixed-citation xml:lang="en">Bhatia R, Alikhan A, Maibach HI. Contact urticaria: present scenario. Indian J Dermatol. 2009;54(3):264–268. doi: 10.4103/0019-5154.55639</mixed-citation><mixed-citation xml:lang="ru">Bhatia R., Alikhan A., Maibach H.I. Contact urticaria: present scenario // Indian J Dermatol. 2009. Vol. 54, N 3. Р. 264–268. doi: 10.4103/0019-5154.55639</mixed-citation></citation-alternatives></ref><ref id="B130"><label>130.</label><citation-alternatives><mixed-citation xml:lang="en">Mowad CM. Contact dermatitis: Practice gaps and challenges. Dermatol Clin. 2016;34(3):263–267. doi: 10.1016/j.det.2016.02.010</mixed-citation><mixed-citation xml:lang="ru">Mowad C.M. Contact dermatitis: Practice gaps and challenges // Dermatol Clin. 2016. Vol. 34, N 3. Р. 263–267. doi: 10.1016/j.det.2016.02.010</mixed-citation></citation-alternatives></ref><ref id="B131"><label>131.</label><citation-alternatives><mixed-citation xml:lang="en">Japundžić I, Vodanović M, Lugović-Mihić L. An analysis of skin prick tests to latex and patch tests to rubber additives and other causative factors among dental professionals and students with contact dermatoses. Int Arch Allergy Immunol. 2018;177(3):238–244. doi: 10.1159/000490181</mixed-citation><mixed-citation xml:lang="ru">Japundžić I., Vodanović M., Lugović-Mihić L. An analysis of skin prick tests to latex and patch tests to rubber additives and other causative factors among dental professionals and students with contact dermatoses // Int Arch Allergy Immunol. 2018. Vol. 177, N 3. Р. 238–244. doi: 10.1159/000490181</mixed-citation></citation-alternatives></ref><ref id="B132"><label>132.</label><citation-alternatives><mixed-citation xml:lang="en">Pondeljak N, Lugović-Mihić L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Ther. 2020;42(5):757–770. doi: 10.1016/j.clinthera.2020.03.008</mixed-citation><mixed-citation xml:lang="ru">Pondeljak N., Lugović-Mihić L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters // Clin Ther. 2020. Vol. 42, N 5. Р. 757–770. doi: 10.1016/j.clinthera.2020.03.008</mixed-citation></citation-alternatives></ref><ref id="B133"><label>133.</label><citation-alternatives><mixed-citation xml:lang="en">Kai AC, Flohr C. Aquagenic urticaria in twins. World Allergy Organ J. 2013;6(1):2. doi: 10.1186/1939-4551-6-2</mixed-citation><mixed-citation xml:lang="ru">Kai A.C., Flohr C. Aquagenic urticaria in twins // World Allergy Organ J. 2013. Vol. 6, N 1. Р. 2. doi: 10.1186/1939-4551-6-2</mixed-citation></citation-alternatives></ref><ref id="B134"><label>134.</label><citation-alternatives><mixed-citation xml:lang="en">Park H, Kim HS, Yoo DS, et al. Aquagenic urticaria: A report of two cases. Ann Dermatol. 2011;23(Suppl 3):S371–S374. doi: 10.5021/ad.2011.23.S3.S371</mixed-citation><mixed-citation xml:lang="ru">Park H., Kim H.S., Yoo D.S., et al. Aquagenic urticaria: A report of two cases // Ann Dermatol. 2011. Vol. 23, Suppl 3. Р. S371–S374. doi: 10.5021/ad.2011.23.S3.S371</mixed-citation></citation-alternatives></ref><ref id="B135"><label>135.</label><citation-alternatives><mixed-citation xml:lang="en">McGee JS, Kirkorian AY, Pappert AS, Milgraum SS. An adolescent boy with urticaria to water: Review of current treatments for aquagenic urticaria. Pediatr Dermatol. 2014;31(1):116–117. doi: 10.1111/j.1525-1470.2012.01801.x</mixed-citation><mixed-citation xml:lang="ru">McGee J.S., Kirkorian A.Y., Pappert A.S., Milgraum S.S. An adolescent boy with urticaria to water: Review of current treatments for aquagenic urticaria // Pediatr Dermatol. 2014. Vol. 31, N 1. Р. 116–117. doi: 10.1111/j.1525-1470.2012.01801.x</mixed-citation></citation-alternatives></ref><ref id="B136"><label>136.</label><citation-alternatives><mixed-citation xml:lang="en">Wassef C, Laureano A, Schwartz RA. Aquagenic urticaria: A perplexing physical phenomenon. Acta Dermatovenerol Croat. 2017;25(3):234–237.</mixed-citation><mixed-citation xml:lang="ru">Wassef C., Laureano A., Schwartz R.A. Aquagenic urticaria: A perplexing physical phenomenon // Acta Dermatovenerol Croat. 2017. Vol. 25, N 3. Р. 234–237.</mixed-citation></citation-alternatives></ref><ref id="B137"><label>137.</label><citation-alternatives><mixed-citation xml:lang="en">Pozderac I, Lugović-Mihić L, Artuković M, et al. Chronic inducible urticaria: Classification and prominent features of physical and non-physical types. Acta Dermatovenerol Alp Pannonica Adriat. 2020;29(3):141–148.</mixed-citation><mixed-citation xml:lang="ru">Pozderac I., Lugović-Mihić L., Artuković M., et al. Chronic inducible urticaria: Classification and prominent features of physical and non-physical types // Acta Dermatovenerol Alp Pannonica Adriat. 2020. Vol. 29, N 3. Р. 141–148.</mixed-citation></citation-alternatives></ref><ref id="B138"><label>138.</label><citation-alternatives><mixed-citation xml:lang="en">Rorie A., Gierer S. A case of aquagenic urticaria successfully treated with omalizumab. J Allergy Clin Immunol Pract. 2016;4(3): 547–548. doi: 10.1016/j.jaip.2015.12.017</mixed-citation><mixed-citation xml:lang="ru">Rorie A., Gierer S. A case of aquagenic urticaria successfully treated with omalizumab // J Allergy Clin Immunol Pract. 2016. Vol. 4, N 3. Р. 547–548. doi: 10.1016/j.jaip.2015.12.017</mixed-citation></citation-alternatives></ref><ref id="B139"><label>139.</label><citation-alternatives><mixed-citation xml:lang="en">Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45(3):387–391. doi: 10.1067/mjd.2001.116217</mixed-citation><mixed-citation xml:lang="ru">Kozel M.M., Mekkes J.R., Bossuyt P.M., Bos J.D. Natural course of physical and chronic urticaria and angioedema in 220 patients // J Am Acad Dermatol. 2001. Vol. 45, N 3. Р. 387–391. doi: 10.1067/mjd.2001.116217</mixed-citation></citation-alternatives></ref></ref-list></back></article>
